Page 8 - PROSTATE CANCER
P. 8
3. SBRT: RCT prostate vs. prostate and pelvis - (feasibility) ☺
Biomarkers: yH2AX in circulating lymphocytes and serum citruline
30 pts
Short follow up – 2.5y
More toxicity with pelvic RT GU/GI
GU: 13 vs. 0% GI: 20 vs 7%
N=1 gr 3 GU toxicity
Dr. Fairmichael U. of Queens
